Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


07.01.2019

3 Antimicrob Agents Chemother
1 Infect Immun
1 J Immunol
1 J Infect Dis
3 PLoS One
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. GHAJAVAND H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, et al
    High Prevalence of Bedaquiline Resistance in Treatment-naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02530.
    PubMed     Text format     Abstract available

  2. CHOULES MP, Wolf NM, Lee H, Anderson JR, et al
    Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02204.
    PubMed     Text format     Abstract available

  3. KHALIL ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, et al
    Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.01773.
    PubMed     Text format     Abstract available


    Infect Immun

  4. RAFFETSEDER J, Iakobachvili N, Loitto V, Peters PJ, et al
    Retention of EsxA in the capsule-like layer of Mycobacterium tuberculosis is associated with cytotoxicity and is counteracted by lung surfactant.
    Infect Immun. 2019 Jan 2. pii: IAI.00803-18. doi: 10.1128/IAI.00803.
    PubMed     Text format     Abstract available


    J Immunol

  5. SINGH SK, Larsson M, Schon T, Stendahl O, et al
    HIV Interferes with the Dendritic Cell-T Cell Axis of Macrophage Activation by Shifting Mycobacterium tuberculosis-Specific CD4 T Cells into a Dysfunctional Phenotype.
    J Immunol. 2018 Dec 28. pii: jimmunol.1800523. doi: 10.4049/jimmunol.1800523.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. DESHPANDE D, Pasipanodya JG, Srivastava S, Martin KR, et al
    Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
    J Infect Dis. 2018 Dec 28. pii: 5263980. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  7. ZHOU M, Liu S, Li Q, Wang Q, et al
    Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study.
    PLoS One. 2018;13:e0209902.
    PubMed     Text format     Abstract available

  8. HTUN YM, Khaing TMM, Aung NM, Yin Y, et al
    Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.
    PLoS One. 2018;13:e0209932.
    PubMed     Text format     Abstract available

  9. METCALF T, Soria J, Montano SM, Ticona E, et al
    Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
    PLoS One. 2018;13:e0198695.
    PubMed     Text format     Abstract available


    Trop Med Int Health

  10. SOLARI L, Soto A, Van der Stuyft P
    Development of a clinical prediction rule for tuberculous meningitis in adults in Lima, Peru.
    Trop Med Int Health. 2018;23:367-374.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: